210 related articles for article (PubMed ID: 2891100)
1. Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages.
Cabral DA; Loh BA; Speert DP
Pediatr Res; 1987 Oct; 22(4):429-31. PubMed ID: 2891100
[TBL] [Abstract][Full Text] [Related]
2. Opsonin-independent phagocytosis of Pseudomonas aeruginosa.
Speert DP; Loh BA; Cabral DA; Eftekhar F
Antibiot Chemother (1971); 1985; 36():88-94. PubMed ID: 3923915
[TBL] [Abstract][Full Text] [Related]
3. Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay.
LeBlanc CM; Bortolussi R; Issekutz AC; Gillespie T
Clin Invest Med; 1982; 5(2-3):125-8. PubMed ID: 6811181
[TBL] [Abstract][Full Text] [Related]
4. Nonopsonic phagocytosis of strains of Pseudomonas aeruginosa from cystic fibrosis patients.
Speert DP; Eftekhar F; Puterman ML
Infect Immun; 1984 Mar; 43(3):1006-11. PubMed ID: 6421734
[TBL] [Abstract][Full Text] [Related]
5. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.
Pier GB; Saunders JM; Ames P; Edwards MS; Auerbach H; Goldfarb J; Speert DP; Hurwitch S
N Engl J Med; 1987 Sep; 317(13):793-8. PubMed ID: 2957591
[TBL] [Abstract][Full Text] [Related]
6. Nonopsonic phagocytosis of nonmucoid Pseudomonas aeruginosa by human neutrophils and monocyte-derived macrophages is correlated with bacterial piliation and hydrophobicity.
Speert DP; Loh BA; Cabral DA; Salit IE
Infect Immun; 1986 Jul; 53(1):207-12. PubMed ID: 2873104
[TBL] [Abstract][Full Text] [Related]
7. Alginase treatment of mucoid Pseudomonas aeruginosa enhances phagocytosis by human monocyte-derived macrophages.
Eftekhar F; Speert DP
Infect Immun; 1988 Nov; 56(11):2788-93. PubMed ID: 3139564
[TBL] [Abstract][Full Text] [Related]
8. Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis.
Pier GB; Coleman F; Grout M; Franklin M; Ohman DE
Infect Immun; 2001 Mar; 69(3):1895-901. PubMed ID: 11179370
[TBL] [Abstract][Full Text] [Related]
9. Resistance of mucoid Pseudomonas aeruginosa to nonopsonic phagocytosis by alveolar macrophages in vitro.
Krieg DP; Helmke RJ; German VF; Mangos JA
Infect Immun; 1988 Dec; 56(12):3173-9. PubMed ID: 3141284
[TBL] [Abstract][Full Text] [Related]
10. Interaction between Pseudomonas aeruginosa and host defenses in cystic fibrosis.
Marshall BC; Carroll KC
Semin Respir Infect; 1991 Mar; 6(1):11-8. PubMed ID: 1909452
[TBL] [Abstract][Full Text] [Related]
11. Two distinct receptors mediate nonopsonic phagocytosis of different strains of Pseudomonas aeruginosa.
Heale JP; Pollard AJ; Stokes RW; Simpson D; Tsang A; Massing B; Speert DP
J Infect Dis; 2001 Apr; 183(8):1214-20. PubMed ID: 11262203
[TBL] [Abstract][Full Text] [Related]
12. Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains.
Baltimore RS; Mitchell M
J Infect Dis; 1980 Feb; 141(2):238-47. PubMed ID: 6444976
[TBL] [Abstract][Full Text] [Related]
13. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
Meluleni GJ; Grout M; Evans DJ; Pier GB
J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
[TBL] [Abstract][Full Text] [Related]
14. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
Pedersen SS
APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
[TBL] [Abstract][Full Text] [Related]
15. Emergence and persistence of Pseudomonas aeruginosa in the cystic fibrosis airway.
Fick RB; Sonoda F; Hornick DB
Semin Respir Infect; 1992 Sep; 7(3):168-78. PubMed ID: 1475541
[TBL] [Abstract][Full Text] [Related]
16. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
[TBL] [Abstract][Full Text] [Related]
17. Nonopsonic phagocytosis of Pseudomonas aeruginosa requires facilitated transport of D-glucose by macrophages.
Barghouthi S; Everett KD; Speert DP
J Immunol; 1995 Apr; 154(7):3420-8. PubMed ID: 7897223
[TBL] [Abstract][Full Text] [Related]
18. Phagocytosis of mucoid and nonmucoid strains of Pseudomonas aeruginosa.
Meshulam T; Obedeanu N; Merzbach D; Sobel JD
Clin Immunol Immunopathol; 1984 Aug; 32(2):151-65. PubMed ID: 6428788
[TBL] [Abstract][Full Text] [Related]
19. Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis.
Sajjan U; Reisman J; Doig P; Irvin RT; Forstner G; Forstner J
J Clin Invest; 1992 Feb; 89(2):657-65. PubMed ID: 1737853
[TBL] [Abstract][Full Text] [Related]
20. Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins.
Pier GB; Grout M; Desjardins D
J Immunol; 1991 Sep; 147(6):1869-76. PubMed ID: 1832427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
